NorthCrest Asset Manangement’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Buy |
+4,292
| New | +$330K | 0.01% | 498 |
|
|
2025
Q1 | – | Sell |
-2,870
| Closed | -$212K | – | 599 |
|
|
2024
Q4 | $212K | Buy |
+2,870
| New | +$212K | 0.01% | 537 |
|
|
2024
Q3 | – | Sell |
-2,212
| Closed | -$204K | – | 549 |
|
|
2024
Q2 | $204K | Hold |
2,212
| – | – | 0.01% | 492 |
|
|
2024
Q1 | $211K | Buy |
+2,212
| New | +$211K | 0.01% | 489 |
|
|
2023
Q3 | – | Sell |
-2,498
| Closed | -$236K | – | 504 |
|
|
2023
Q2 | $236K | Buy |
2,498
+7
| +0.3% | +$660 | 0.01% | 472 |
|
|
2023
Q1 | $206K | Buy |
+2,491
| New | +$206K | 0.01% | 474 |
|
|
2022
Q3 | – | Sell |
-2,250
| Closed | -$214K | – | 433 |
|
|
2022
Q2 | $214K | Buy |
+2,250
| New | +$214K | 0.01% | 415 |
|
|
2022
Q1 | – | Sell |
-2,250
| Closed | -$291K | – | 425 |
|
|
2021
Q4 | $291K | Buy |
+2,250
| New | +$291K | 0.02% | 365 |
|